Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 19 Issue 7, July 2023

COVER: The intracellular complement system, inspired by the Review on p426.

Cover design: Lara Crow

Comment

  • The advancement of women to leadership positions in nephrology lags behind that of men by several metrics. Proactive, intentional approaches, including mentorship and sponsorship, family-friendly policies, career development in hard and soft skills, combatting bias and use of transparent institutional metrics of women’s advancement, are required to address this disparity.

    • Lisa M. Curtis
    Comment

    Advertisement

  • Blockchains enable secure data storage, the verification of data origin and accurate registration of changes in information over time. The widespread adoption of blockchain in nephrology could affect clinical practice and research by enhancing the quality of electronic health records and datasets.

    • Tamas Szili-Torok
    • Daan Kremer
    • Martin H. de Borst
    Comment
Top of page ⤴

Research Highlights

Top of page ⤴

Reviews

  • Complement proteins and receptors with intracellular activity — the complosome — have emerged as important regulators of physiological processes. In this Review, the authors examine evidence of complosome activity across a variety of cells and tissues, as well as their contributions to human disease and therapeutic potential.

    • Erin E. West
    • Claudia Kemper
    Review Article
  • Renal cell carcinoma is sensitive to immune checkpoint blockade despite having a moderate traditional tumour mutational burden profile. Here, the authors discuss how the high prevalence of frameshift insertion or deletions in renal cell carcinoma, as well as the reactivation of endogenous retroviral gene expression, might provide alternative neoantigens that potentiate responses to immunotherapy.

    • Melissa M. Wolf
    • W. Kimryn Rathmell
    • Aguirre A. de Cubas

    Series:

    Review Article
  • Despite advances in cell and gene therapy for the treatment of disease, no such interventions currently target the kidney. Here, the authors review the potential for cell and gene therapies to be applied to kidney disease, highlighting recent genetic studies, key technical advances and considerations, and areas for further investigation.

    • Jennifer L. Peek
    • Matthew H. Wilson
    Review Article
  • In this Review, the authors describe biological networks, discuss the properties that make these networks ideal for understanding how diseases arise from complex interactions of molecular and cellular systems, and explore how network medicine can be used to improve understanding of kidney and renovascular diseases.

    • Arvind K. Pandey
    • Joseph Loscalzo
    Review Article
Top of page ⤴

Search

Quick links